...
首页> 外文期刊>Clinical and experimental nephrology >Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review.
【24h】

Dipsogenic diabetes insipidus: report of a novel treatment strategy and literature review.

机译:致尿崩症:一种新型治疗策略的报告和文献综述。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Dipsogenic diabetes insipidus is a syndrome of disordered thirst, in patients without psychiatric disease, which may be confused with partial central diabetes insipidus. Distinguishing these entities involves monitored water testing. Therapy with antidiuretic hormone in patients with dipsogenic diabetes insipidus is thought to be contraindicated for fear of inducing water intoxication. We report a case of a 26-year-old woman without psychiatric illness referred for longstanding polyuria and polydipsia. Otherwise healthy, she complained of near-constant thirst and frequent urination, causing severe disruption of her personal and professional life. She had been consistently eunatremic and polyuric, with low urine osmolality. Results of extensive water testing revealed intact urinary concentrating and diluting capacity, physiologic though blunted antidiuretic hormone (ADH) release, and an abnormally low thirst threshold, consistent with the diagnosis of dipsogenic diabetes insipidus. To control her polyuria we initiated treatment with intermittent, low-dose, intranasal desmopressin and strict water restriction during drug dosing. In follow-up she reported excellent control of polyuria and significant functional improvement. The reviewed literature demonstrates a limited number of reports about dipsogenic diabetes insipidus, and no prior report of a similar treatment strategy. Dipsogenic diabetes insipidus is an uncommonly (and not universally) recognized disorder, requiring monitored testing in order to distinguish it from incomplete forms of central diabetes insipidus. Though therapy with desmopressin cannot be recommended based on the results of a single case, the outcome presented here is intriguing and suggests that larger studies in such patients is warranted to assess the broader application of such an intervention.
机译:在没有精神疾病的患者中,发散性尿崩症是口渴失调的综合症,可能与部分中枢性尿崩症相混淆。区分这些实体涉及受监控的水测试。由于担心诱发水中毒,因此被认为是禁忌性尿崩症患者的抗利尿激素疗法。我们报告了一例26岁的女性,因长期的多尿和多饮而无精神病。否则,她健康,抱怨口渴和尿频不断,严重破坏了她的个人和职业生活。她一直是尿毒症和多尿症,尿渗透压低。大量的水测试结果表明,完整的尿液浓缩和稀释能力,生理性的抗利尿激素(ADH)释放虽然较钝,并且口渴阈值异常低,这与诊断为尿崩症的患者相一致。为了控制她的多尿症,我们在给药期间采用间歇性,低剂量,鼻内去氨加压素和严格的限水措施开始治疗。在随访中,她报告了多尿症的良好控制和明显的功能改善。综述的文献表明,有关致双源性尿崩症的报道很少,也没有关于类似治疗策略的报道。发散性尿崩症是一种罕见的(不是普遍的)公认的疾病,需要进行监测测试才能将其与不完整的中枢性尿崩症区别开来。尽管不能根据单个病例的结果推荐去氨加压素治疗,但此处提出的结果很有趣,并建议对此类患者进行更大规模的研究以评估此类干预措施的广泛应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号